⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 15, 2024Neurogastroenterology & MotilityOpen Access

Effect of Iberogast (STW5) on tolerance to colonic gas in patients with irritable bowel syndrome: A randomized, double‐blind, placebo control clinical trial

Ariadna Aguilar Bouchra Benslaiman Jordi Serra

View Full Paper

Ask AI

Bookmark

Share

Abstract

STW5 is an herbal medicinal product that, in previous studies, reduced abdominal pain in irritable bowel syndrome (IBS). The effect of STW5 on gas-related abdominal symptoms is unknown.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Aguilar et al. (2024) studied this question.

synapsesocial.com/papers/68e79082b6db6435877019ec https://doi.org/10.1111/nmo.14765

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Rapid biotransformation of STW 5 constituents by human gut microbiome from IBS- and non-IBS donors2024 · 5 citations
2Double‐blind, randomized, 8‐week multicenter study of the efficacy and safety of <scp>STW 5‐II</scp><i>versus</i> placebo in functional dyspepsia2024 · 8 citations
3Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel SyndromeRCT · 2016 · 301 citations
4Clinical Trial: Randomised Placebo‐Controlled Trial of Methylcellulose and Psyllium Gels on Inulin‐Induced Colonic GasClinical Trial · 2026 · 1 citations
5A randomised, placebo-controlled trial in healthy humans of modified cellulose or psyllium evaluating the role of gelation in altering colonic gas production during inulin co-administrationOriginal Research · 2026 · 3 citations